spacer
home > pmps > winter 2002 > clinical trial supplies - the essential link
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Clinical Trial Supplies - The Essential Link

Strategically positioned within the bio/pharma development pipeline, at the very centre of the clinical trials process, resides a 'hardware' component: the test article or clinical trial material (CTM).

The outcome of field tests for this essential link in the chain is crucial to future success of investment in R&D. Given the strategic importance of procuring CTM, it's not surprising that the complex clinical trial supplies (CTS) business absorbs a hefty chunk of a sponsor's development budget. Trials can no longer be set up in-house using homemade trial packs, labelled by hand and randomly assigned to patients with little or no control. Today's CTS business is a slick, highly sophisticated operation which is considered a microcosm of the wider pharmaceutical industry. This article will review aspects of the modern CTS business.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Dr Patricia Lobo, Editor of PMPS and Senior Consultant in CTS and Manufacturing at Technomark Consulting Services Ltd
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement